Bipolar Disorder Clinical Trial
Official title:
Assessment of Occupational Stress and Well-being in French Patients Suffering From Bipolar Disorder
NCT number | NCT03162380 |
Other study ID # | RECHMPL17_0138 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 22, 2017 |
Est. completion date | June 30, 2018 |
Verified date | September 2018 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Bipolar disorder is a mental disorder characterized by alternance of depressive and manic
phases, separated by intercritical phases (euthymia). The majority of patients report
occupation and professional difficulties. Sixty percent of bipolar patients are inactive .
Indeed, according to the World Health Organisation, bipolar disorder is the second cause of
days not worked.
Several factors are related to the lower professional functioning observed in bipolar
patients: early age of onset, delay of diagnosis and treatment, recurrence of thymic
episodes, residual symptoms and cognitive disorders during euthymia, side effects of mood
stabilizers.
To our knowledge, no study has ever focused on well-being at work in French patients.
However, suffering from a psychiatric disorder and the lack of support from colleagues and
the hierarchy are risk factors for burnout, a growing health issue.
Patients with mental illness are often victims of stigmatization, which may involve the
professional field. In addition, thymic recurrences may alter professional functioning of
active patients: multiplication of work disruptions, conflicts with peers. Conversely work
can be stressful, promoting thyic relapses. It is therefore essential to better understand
the occupational stresses of active patients suffering from bipolar disorder in order to
promote functional remission beyond clinical remission.
The aim of this study is to assess the level of stress and well-being at work in active
French bipolar patients.
Status | Completed |
Enrollment | 200 |
Est. completion date | June 30, 2018 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - out patients and inpatients in the Department of Emergency Psychiatry and Post Acute Care, CHU Montpellier, France - to have completed the self-administered questionnaire on professional activity. Exclusion Criteria: - Deprived of liberty subject (by judicial or administrative decision) - Protected by law (guardianship) |
Country | Name | City | State |
---|---|---|---|
France | Uhmontpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Level of occupational stress using a Likert scale | level of occupational stress assessed at the patient visit will be collected, from 0 (none) to 10 (maximum possible occupational stress). | 1 day | |
Secondary | Presenteism during the last month using the Stanford Presenteeism Scale | Presenteism during the last month assessed at the patient visit will be collected | 1 day | |
Secondary | Support of colleagues and superiors using the Karasek questionnaire. | Support of colleagues and superiors assessed at the patient visit will be collected | 1 day | |
Secondary | Impact of work on the private sphere using the SWING scale (survey work-home interaction-Nijmegen) | Impact of work on the private sphere assessed at the patient visit will be collected | 1 day | |
Secondary | Balance effort - reward in using the Siegrist questionaire | Balance effort - reward assessed at the patient visit will be collected | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |